TROXEVASIN 20mg / g gel medication leaflet

C05CA04 troxerutine • Cardiovascular system | Capillary stabilizing agents | Bioflavonoids

Troxerutin is a semisynthetic flavonoid used in the treatment of chronic venous disorders such as chronic venous insufficiency, varicose veins, and hemorrhoids. This compound has antioxidant, anti-inflammatory, and vasoprotective properties, helping to reduce inflammation and improve venous tone.

Troxerutin is available in the form of capsules, tablets, or topical gels. Oral administration is used to treat systemic symptoms such as pain, swelling, and a feeling of heaviness in the legs, while gels are applied locally to relieve skin-level symptoms.

Side effects are rare but may include allergic reactions, nausea, or gastric discomfort. It is important to use troxerutin as directed by a physician, especially in patients with pre-existing conditions.

Troxerutin is an effective therapeutic option for managing chronic venous disorders, helping to reduce symptoms and improve patients' quality of life.

General data about TROXEVASIN 20mg / g

Substance: troxerutine

Date of last drug list: 01-07-2021

Commercial code: W67679003

Concentration: 20mg / g

Pharmaceutical form: gel

Quantity: 1

Product type: generic

Prescription restrictions: OTC - Over the Counter = medicines that do not require a prescription.

Marketing authorisation

Manufacturer: BALKANPHARMA-TROYAN AD - BULGARIA

Holder: TEVA PHARMACEUTICALS S.R.L. - ROMANIA

Number: 8820/2016/03

Shelf life: 5 years

Pharmaceutical forms available for troxerutine

Concentrations available for troxerutine

1000mg, 2%, 20mg/g, 300mg, 3500mg

Other substances similar to troxerutine